Login / Signup

Use of advanced heart failure therapies in Duchenne muscular dystrophy.

Carol A Wittlieb-WeberChet R VillaJennifer ConwayMatthew J BockKatheryn E GambettaJonathan N JohnsonAshwin K LalKurt R SchumacherSabrina P LawShriprasad R DeshpandeShawn C WestJoshua M Friedland-LittleIrene D LytriviMichael A McCullochRyan J ButtsDavid R WeberKenneth R Knecht
Published in: Progress in pediatric cardiology (2019)
Advanced HF therapies may be used effectively in select subjects with DMD. Further studies are needed to better understand risk stratification for ICD use and optimal candidacy for LVAD implantation and HTX, with hopes of improving cardiac outcomes.
Keyphrases
  • duchenne muscular dystrophy
  • heart failure
  • left ventricular
  • acute heart failure
  • atrial fibrillation
  • case control
  • adipose tissue
  • metabolic syndrome
  • insulin resistance
  • glycemic control